WMT AG
General information
WMT AG
Waldhofer Str. 104
69123 Heidelberg, Baden-Württemberg
Germany
Contact person: Claus Kremoser, Chief Executive Officer
Company main phone: +49 (6221) 65282-0
Website: https://wm-therapeutics.com/
Waldhofer Str. 104
69123 Heidelberg, Baden-Württemberg
Germany
Contact person: Claus Kremoser, Chief Executive Officer
Company main phone: +49 (6221) 65282-0
Website: https://wm-therapeutics.com/
| Year founded: | 2020 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
WMT develops small-molecule therapies for late-stage solid tumors by targeting Warburg metabolism—the elevated glycolysis and lactate production characteristic of cancer cells. Its anti-Warburg Warheads (AWWs) reduce lactate levels in the tumor microenvironment, thereby inhibiting tumor growth and reactivating anti-tumor immune responses.
WMT develops small-molecule therapies for late-stage solid tumors by targeting Warburg metabolism—the elevated glycolysis and lactate production characteristic of cancer cells. Its anti-Warburg Warheads (AWWs) reduce lactate levels in the tumor microenvironment, thereby inhibiting tumor growth and reactivating anti-tumor immune responses.
State of ownership: Private / independent
Headquarters: HQ: Yes
Headquarters: HQ: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
© 2026 Biotechgate by Venture Valuation